CagriSema Dose Escalation Protocol The cagrilintide dosage with semaglutide follows its own escalation schedule, with both compounds increasing in tandem: The maintenance dose for CagriSema settles at cagrilintide 2.4 mg plus semaglutide 2.4 mg weeklynotably lower than the 4.5 mg monotherapy dose for cagrilintide
Its main rival in the US weight-loss category, Eli Lilly, is currently waiting for an FDA decision on its oral GLP-1 agonist orforglipron in the second quarter of this year
Other medications you may be taking alongside your GLP-1, including metformin, ACE inhibitors, and beta-blockers, can also cause hair loss and should be reviewed
FDA Warns Against Compounded Semaglutide for Diabetes, Weight Loss Key takeaways : The FDA has recently issued warnings to companies offering compounded medications with false or misleading claims that their medications are FDA-approved and equivalent in safety to approved drugs like Ozempic
Performance Enhancing Hormone Doping in Sport
Interestingly, research suggests that GLP-1 may be impaired in some people with obesity, even if they have a normal glucose tolerance